1f58500386b609f4…

{
  "id": "NCT00141661",
  "type": "Study",
  "data": {
    "briefSummary": "A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease.",
    "completionDate": "2006-06",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": 67,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00141661",
    "phase": "PHASE2",
    "sponsorId": "pfizer",
    "startDate": "2005-10",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "A Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study in Subjects With Mild to Moderate Dementia of the Alzheimer's Type to Evaluate the Safety and Tolerability of Two 10-Week Dose Regimens of Orally-Administered PF-04494700",
    "url": "https://clinicaltrials.gov/study/NCT00141661"
  }
}